Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Robert Mokszycki"'
Autor:
Nicholas Panos, Megan A. Rech, Robert Mokszycki, Rolla T. Sweis, Joshua M. DeMott, Gary D. Peksa, Brian Maynard
Publikováno v:
Thrombosis and Haemostasis. 120:207-215
Background Warfarin-associated major hemorrhage is frequently treated with prothrombin complex concentrates to correct international normalized ratio (INR). Objective This article aims to investigate the efficacy of activated prothrombin complex conc
Autor:
Marc McDowell, Lauren Stambolic, Sabrin Jaber, Brook Walsh, Ellen Omi, Nadine Alwawi, Dharati Desai, Stephany Nunez Cruz, Jaxson Burkins, Nadine Lomotan, Peter Herout, Barb Bukowski Gorno, Robert Mokszycki
Publikováno v:
Critical Care Medicine. 51:645-645
Publikováno v:
The American Journal of Emergency Medicine. 48:377.e1-377.e3
Ventricular tachycardia (VT) is a major contributor to sudden cardiac death, and pharmacologic treatment options beyond antiarrhythmics are limited. Emerging data suggest sympathetic blocking agents such as propofol are a potential management option
Publikováno v:
Academic emergency medicine : official journal of the Society for Academic Emergency MedicineReferences. 27(1)
Publikováno v:
Expert review of medical devices. 15(6)
Health care providers are increasingly challenged to balance cost considerations for devices, drugs, and staffing all while continuing to provide excellent care. Patients in both the post-acute and acute care settings often require fluid and/or medic
Autor:
Neal Lyons, Braden Parker, Rolla T. Sweis, Erik Kulstad, Robert Mokszycki, Kathleen Hesse, Kelly Wesselhoff, Akilesh Honasoge
Publikováno v:
Journal of Visualized Experiments : JoVE
The available routes of administration commonly used for medications and fluids in the acute care setting are generally limited to oral, intravenous, or intraosseous routes, but in many patients, particularly in the emergency or critical care setting
Publikováno v:
The American Journal of Emergency Medicine. 37:1808.e5-1808.e6
Thrombolytics and extracorporeal membrane oxygenation (ECMO) are potential management options for massive pulmonary embolism (PE). There are early data supporting the use of repeated alteplase 50 mg bolus for massive PE. However, there is sparse lite
Autor:
Megan A. Rech, Robert Mokszycki, Nicholas Panos, Gary D. Peksa, Brian Maynard, Joshua M. DeMott
Publikováno v:
Critical Care Medicine. 46:443-443
Publikováno v:
Pharmacotherapy. 35(3)
Vilazodone is a new selective serotonin reuptake inhibitor (SSRI) and serotonin 5-HT1a partial agonist that is approved by the United States Food and Drug Administration to treat major depression. SSRI-induced seizures are rare and are more likely to
Autor:
Stephen Jamieson, Daniel Nejak, Erik Kulstad, Robert Mokszycki, Marc McDowell, Nadine Lomotan, Neal Lyons
Publikováno v:
The American Journal of Emergency Medicine. (8):1113.e5-1113.e6
Routes of administration for medications and fluids in the acute care setting have primarily focused on oral, intravenous, or intraosseous routes, but, in many patients, none of these routes is optimal. A novel device (Macy Catheter; Hospi Corp) that